These analyses also support the use of a 5-point threshold for meaningful within-patient worsening (mean, 4.98 points
A degraded semaglutide molecule cannot bind to GLP-1 receptors properly, which means reduced efficacy or no efficacy at all
Multiple CDMOs are already active across the GLP-1 value chain, including those involved in drug manufacturing, such as Corden Pharma (Astorg), Axplora (Bridgepoint) and AmbioPharma (Carlyle)
refer to the BNF and product SmPC for eligibility, dosing, and monitoring requirements
The velocity during this period averaged approximately 1.7 lb per week
Understanding how long peptides take to work across different categories provides a realistic framework for setting expectations during the escalation phase